
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 391
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT04092816 | Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention | ||
NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | ||
NCT04083495 | CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma | ||
NCT03089606 | Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker | ||
NCT04176497 | PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study | ||
NCT01571024 | BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer | ||
NCT03694834 | Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer | ||
NCT00486304 | Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy | ||
NCT01665703 | Imaging Correlates of Renal Cell Carcinoma Biological Features | ||
NCT01323062 | Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects | ||
NCT04585893 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | ||
NCT04700527 | The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study | ||
NCT02191969 | Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer | ||
NCT00998101 | Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | ||
NCT00280787 | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | ||
NCT03862105 | Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer | ||
NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | ||
NCT01175967 | Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer | ||
NCT05413811 | Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV | ||
NCT04432753 | Effect of Incidental Findings Information on Lung Cancer Screening Intent | ||
NCT00312637 | Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease | ||
NCT03914885 | Compassionate Use Re-Infusion of ATLCAR.CD30 | ||
NCT04021238 | Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging | ||
NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | ||
NCT05754749 | Comparison of CE-DBT and MRI in Patients With Known Breast Lesions | ||
NCT06096038 | Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC | ||
NCT03696784 | Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma | ||
NCT00257426 | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | ||
NCT06855654 | Promoting Resilience in Women With Breast Cancer (PRISM -MBC) | ||
NCT04271254 | PET/MR Characterization of Renal Cell Carcinomas | ||
NCT06483555 | Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel | ||
NCT01137825 | Registry of Older Patients With Cancer | ||
NCT05736718 | Engaging Clinical Champions to Improve HPV Vaccination | ||
NCT06902311 | Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) | ||
NCT03361800 | Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC | ||
NCT00099008 | Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women | ||
NCT00448357 | Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen | ||
NCT01138345 | Biomarkers in Blood Samples From Older Breast Cancer Survivors | ||
NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | ||
NCT00719173 | Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer | ||
NCT02564120 | North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | ||
NCT02043470 | Retinal Oxygen Function After Radiation Therapy | ||
NCT05744960 | Impact of Financial Incentives | ||
NCT03488862 | Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients | ||
NCT01655745 | Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer | ||
NCT05414097 | Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa | ||
NCT00519831 | Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC | ||
NCT05498220 | Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
NCT01992068 | Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal Function | ||
NCT03978624 | Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer |